Profile
ACIU NVO VRTX REGN SGEN ARGX
Company Name AC Immune SA Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $322.96M $456.40B $116.20B $80.34B $43.15B $35.73B
Employees 0.13K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Dr. Andrea Pfeifer Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ACIU NVO VRTX REGN SGEN ARGX
Quant Rating Score 3 3 3 4 3 1
Quant Rating Neutral Neutral Neutral Buy Neutral Strong Sell
Trading
ACIU NVO VRTX REGN SGEN ARGX
Last Close $3.24 $105.27 $451.23 $743.35 $228.74 $591.82
High 52 $5 $146.91 $516.74 $1201.76 $228.74 $602.47
Low 52 $2.29 $101.74 $392.81 $743.35 $228.74 $356.01
Price vs. 52 Week High -35.2 % -28.34 % -12.68 % -38.14 % 0 % -1.77 %
Price vs. 52 Week Low 41.48 % 3.47 % 14.87 % 0 % 0 % 66.24 %
Total Return
ACIU NVO VRTX REGN SGEN ARGX
1 Month Return 5.54 % -10.28 % -5.62 % -23.25 % 0 % 5.6 %
3 Month Return -3.57 % -22 % -7.18 % -37.29 % 0 % 12.62 %
6 Month Return -2.99 % -22.11 % 2.09 % -25.21 % 0 % 65.93 %
9 Month Return -2.99 % -12.95 % 7.53 % -21.99 % 0 % 47.97 %
YTD Return -35.2 % 1.76 % 10.9 % -15.36 % 0 % 55.57 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACIU NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.42 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) 67.05 % 1.24 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 0.21 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
ACIU NVO VRTX REGN SGEN ARGX
Asset Growth -1.68 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth 29.43 % 32.32 % 9.25 % 6.49 % 22.93 % 190.7 %
Revenue Growth 276.14 % 31.26 % 10.17 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year -18.57 % 90.51 % 59.87 % 55.67 % 91.84 % 2074.24 %
Revenue 5 Year 50.22 % 124.2 % 218.58 % 110.3 % 215.48 % 3040.37 %
Revenue 10 Year -17.87 % 66.11 % 608.27 % 549.62 % 494.04 % 9013.37 %
EBIT Growth 24.31 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Net Income Growth 23.35 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share 25.87 % 106.79 % 34.59 % 13.48 % -764.83 % 63.97 %
Net Income 5 Yeari Growth Per Share 22.28 % 133.86 % 70.33 % 74.02 % -276.93 % -143.56 %
Net Income 10 Yeari Growth Per Share -131.17 % 98.61 % 809.6 % 871.12 % -624.16 % -857.4 %
Operating Income Growth 24.31 % 37.11 % -12.94 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) 17.89 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG 13.84 % 118.29 % 9.63 % 76.95 % -148.34 % 21.62 %
Operating 5 Year CFG -0.06 % 163.51 % 174.78 % 125.17 % -195.86 % -329.48 %
Operating 10 Year CFG -46.18 % 150.92 % 6084.35 % 713.56 % -2622.09 % -1280.79 %
EPS Growth 24.71 % 52.28 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth 24.71 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -6.22 % 29 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share -36.71 % 75.22 % 104.06 % 137.56 % 33.92 % 93.95 %
Share Holder 5 Year Equity Growth Per Share -33.97 % 121.9 % 291.14 % 219.1 % 220.81 % 318.67 %
Share Holder 10 Year Equity Growth Per Share 1858.45 % 49.62 % 1030.79 % 1286.9 % 691.19 % 3655.65 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth 24.85 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth 18.18 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
ACIU NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM -14.58 % 84.66 % 86.1 % 83.54 % 72.37 % 86.82 %
Return on Assets TTM -16.32 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -28.53 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -26.04 % 62.9 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 106.87 % 100.27 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -91.04 % 43.96 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM - 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM 1.56 3.4 6.06 2.27 1.98 3.45
Payables Turnover TTM 33.15 1.72 3.73 4.58 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.76 0.65 0.91
Fixed Asset Turnover TTM 703.16 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 16.78 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM 0.44 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM 0.43 15.05 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 158.15 % 1681.3 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM 106.7 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 98.51 % 56.7 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM - 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM 6.63 48.27 -99.85 23.78 -141.85 -169.15
Price To Operating Cash Flows Ratio TTM 6.54 28.12 -138.16 18.92 -203.89 -244.33
Price Cash Flow Ratio TTM 6.54 28.12 -138.16 18.92 -203.89 -244.33
Income Statement (TTM)
ACIU NVO VRTX REGN SGEN ARGX
Revenue $0.01B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0.04B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio -268.93% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.05B $114.63B $4.61B $4.65B $-0.62B $-0.22B
Net Income $-0.05B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -0.64 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
ACIU NVO VRTX REGN SGEN ARGX
Long Term Debt $0B $20.53B $1.45B $2.7B $0.04B $0.02B
Total Liabilities $0.02B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.16B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.02B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.18B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
ACIU NVO VRTX REGN SGEN ARGX
Net Income $-0.05B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.26
ABCL AbCellera Biologics Inc. 2.66
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.74
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.35
ABSI Absci Corporation 2.5934
ABUS Arbutus Biopharma Corporation 3.4432
ABVC ABVC BioPharma, Inc. 0.575
ABVX Abivax SA American Depositary Shares 8.76
ACAD ACADIA Pharmaceuticals Inc. 15.7395
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 0.9316
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.05
ACHV Achieve Life Sciences, Inc. 4.285
ACLX Arcellx, Inc. 87.36
ACRV Acrivon Therapeutics, Inc. Common Stock 6.485
ACST Acasti Pharma Inc. 3.37
ACXP Acurx Pharmaceuticals, Inc. 1.342
ETFs With Exposure to ACIU
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.02125 134.03
GWX SPDR S&P International Small Cap ETF 0.02 31.615
BIB ProShares Ultra Nasdaq Biotechnology 0.0113358 54.39
SBIO ALPS Medical Breakthroughs ETF 0.0022 37.17
BMED BlackRock Future Health ETF 0.11258 25.0699
IBBQ Invesco Nasdaq Biotechnology ETF 0.035 22.07
DFAT Dimensional U.S. Targeted Value ETF 0.00004366 58.6578
DFAS Dimensional U.S. Small Cap ETF 0.00024608 68.01
DFAC Dimensional U.S. Core Equity 2 ETF 0.00013301 35.5095
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03527 6.098
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03347 6.41
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.03347 6.415
QQQS Invesco NASDAQ Future Gen 200 ETF 0.518 27.15
DFSU Dimensional US Sustainability Core 1 ETF 0.00054162 38.5599
DXUV Dimensional ETF Trust 0.00013856 54.49
Unlock